Skip to main content
All lobbying filings

ALSTON & BIRD LLP

ALSTON & BIRD LLP filed a Q2 report for VERTEX PHARMACEUTICALS INCORPORATED on July 20, 2026, reporting $50,000 in lobbying income.

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Pharmaceutical Manufacturer

All filings by ALSTON & BIRD LLP · Everything VERTEX PHARMACEUTICALS INCORPORATED has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Budget/Appropriations

FY2027 Appropriations bills.

Health Issues

FY2027 Appropriations bills.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem